NCT03104517: Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
- State
- Under way
- Phase
- Phase 3
- People
- 96 planned
- Started
- 23 Apr 2019
- Primary completion
- 11 Jun 2026
- Arms
- AMDC-USR (iltamiocel)
- Results
- None posted
- 7 Apr 2017: Trial registered
- 23 Apr 2019: Trial started